Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
2.9K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.9K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
01:20COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Variants in the L12 linker domain of KRT10 are causal to atypical epidermolytic ichthyosis.
The Journal of dermatology·2024
Same author
[The relationship of mental health providers with health insurers; an exploration].
Tijdschrift voor psychiatrie·2024
Related Experiment Video
Updated: Mar 11, 2026
04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
1.6K
[Two sisters with lung emphysema].
I Piscaer1, F M E Franssen, N H T Ten Hacken
1Radboud Universiteit, Nijmegen.
Nederlands Tijdschrift Voor Geneeskunde
|November 24, 2016
Summary
Alpha1-antitrypsin deficiency causes early-onset emphysema. Alpha1-antitrypsin augmentation therapy is effective but not reimbursed in the Netherlands, necessitating policy reconsideration.
More Related Videos
Area of Science:
- Pulmonology
- Genetics
- Pharmacology
Background:
- Alpha1-antitrypsin (AAT) is a key antiprotease produced in the liver, protecting lung tissue from protease damage.
- Genetic mutations, particularly the Z-genotype, lead to AAT deficiency, causing low serum AAT levels.
- This deficiency is a rare but significant cause of early-onset emphysema, an orphan phenotype of COPD.
Observation:
- Two sisters presented with early-onset emphysema, indicative of severe AAT deficiency.
- Current treatment involves AAT augmentation therapy, which is not covered by Dutch health insurance.
Findings:
- A recent randomized placebo-controlled study demonstrated the efficacy of AAT augmentation therapy.
- CT lung densitometry confirmed the therapy's protective effect against progressive emphysema.
Implications:
- Reconsideration of health insurance coverage for AAT augmentation therapy in the Netherlands is crucial.
- Improved access to this therapy can benefit patients with AAT deficiency-induced emphysema.
- This highlights the need for recognizing and treating rare genetic lung diseases.